Commentary
Commentary
When to prescribe semaglutide?
When considering an antiobesity medication for a patient, it’s important to discuss efficacy, side-effect profile, contraindications, cost and...
Commentary
Hormone replacement therapy for postmenopausal osteoporosis
Postmenopausal osteoporosis can have far-reaching consequences on one’s quality of life.
Commentary
Overburdened: Health care workers more likely to die by suicide
It’s time we acknowledge and support the people in our profession who seem to be suffering more than any of us: the aides, the techs, the support...
Commentary
The ‘triple-G’ agonist for obesity management: Five things to know
Results from a phase 2 trial published in June 2023 showed a weight loss of 24%...
Pearl of the Month
More on using expired medications
The expiration date is a date, required by law, that the manufacturer can guarantee greater than 90% original potency of the medication.
Commentary
Two landmark papers change treatment paradigm for advanced endometrial cancer
The outcomes we have now are remarkably positive for patients and have absolutely changed the standard of care in the management of recurrent or...
Commentary
Laboratory testing: No doctor required?
Shouldn’t we allow people to get the tests they want, at least if they are willing to pay for it? Of course, it’s not quite that simple.
Commentary
SCD in athletes: Lessons from high-profile cases
There are certainly things that we know we should be intervening on and others where participation is a question. All of these we are trying to...
The Optimized Doctor
The differential diagnosis you’re missing
An itchy 73-year-old woman came to see me. She had seen several competent dermatologists, had comprehensive workups, and had reasonable, even...
Commentary
Smartphones for children with type 1 diabetes: Cause for concern?
As health care professionals, we owe it to our patients to discuss the ups and downs of technology with our patients. We can’t ostrich our way...
Commentary
The safety of vaginal estrogen in breast cancer survivors
Concomitant use of vaginal estrogen and aromatase inhibitors was associated with a higher risk for breast cancer recurrence than was use of...